Search
for
Sort by
Research 331–360 of 1000+
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- A Comprehensive Review of Current Anti-Aging Mechanisms and Therapeutic Approaches
- Low-Level Laser Therapy: A Comprehensive Review of Anti- Inflammatory Applications and Therapeutic Potential
- Evaluation of hydro-alcoholic extract of Eclipta alba for its anticancer potential: An in vitro study
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- In Vivo Evaluation of<i>Eclipta alba</i>Extract as Anticancer and Multidrug Resistance Reversal Agent
- HDL as Therapeutic Tools
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Low Level Laser and Light Therapy
- Survey on adverse events associated with drug therapy for breast cancer patients
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Exosomes as Emerging Therapeutics in Aesthetic and Regenerative Medicine: A Scoping Review
- TRAIL sensitization of PC3 prostate cancer cells by doxorubicin can be blocked by the anti-oxidant N-acetyl-cysteine or by the iron chelator deferoxamine
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- Contemporary medical therapy for polycystic ovary syndrome
- Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma
- Efficacy of stem cell therapy for burn wounds: a systematic review and meta-analysis of preclinical studies
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects